| Size & multiples | |||
| Market Cap | $9.94B | Enterprise Value | $8.66B |
| P/E (TTM) | 21.90× | PEG (trailing) | — |
| P/S | 18.11× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | 15.79× | EV/FCF | — |
| FCF Yield | −0.79% | Buyback Yield | — |
| Owner Earnings (TTM) | $456.9M | Owner Earnings Yield | 4.60% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.21 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 5.07% |
| After-tax Cost of Debt | 2.68% | WACC | 5.05% |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF sits 117% below owner earnings — spending above maintenance (growth capex) or absorbing working capital, so FCF understates the steady-state cash the business throws off.
Flows latest annual · EPS TTM $0.52 · revenue TTM $548.5M · FCF TTM -$78.8M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| Net Margin | 83.3% | -21.2% | -325.3%–7.2% | 98 ↑strong |
| Operating Margin | -7.1% | -34.5% | -552.0%–8.0% | 62 ↑strong |
| ROE | 45.7% | -36.8% | -92.5%–4.5% | 97 ↑strong |
